Article

LENSAR, TrueVision to integrate technologies

LENSAR and TrueVision 3D Surgical have made a global co-development and distribution agreement that integrates TruVision’s overlay and nomogram-the TrueGuide system-into LENSAR’s laser system’s advanced technology suite.

 

Orlando, FL and Santa Barbara, CA-LENSAR and TrueVision 3D Surgical have made a global co-development and distribution agreement that integrates TruVision’s overlay and nomogram-the TrueGuide system-into LENSAR’s laser system’s advanced technology suite.

“Surgeons using the laser system with our proprietary augmented reality image and guidance will now have the added benefit of TrueVision’s overlay and nomogram, which will be incorporated seamlessly into LENSAR’s efficient surgical suite,” said Nick Curtis, chief executive officer of LENSAR. “This deal is a continuation of our commitment to drive innovation and advance refractive cataract surgery.”

The laser system-which is an intelligent femtosecond cataract surgery laser that offers imaging, measurement, and 3-dimensional modeling technology-integrated with the nomogram, premiered last week at the American Society of Cataract/Refractive Surgery annual symposium and congress in Boston.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.